C-U5MXNeuroTrack
digital cognitive screening, cognitive assessment, eye-tracking research
diagnostics
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-U5MX
C-U5MXC-U5MXdigital cognitive screening, cognitive assessment, eye-tracking research
0-100 chain-logic scale · 15 dimensions · scored on public evidence
The Digital Cognitive Multi-domain Alzheimer's Risk Velocity (DC MARVEL) study is a 2-year randomized controlled trial on dementia prevention. The purpose of this study is to determine the effect of a digital cognitive health program on dementia risk, cognitive function, and general health outcomes in middle age to older adults compared to a control group that receives health education.
Exhibitor Profile - PMWC Precision Medicine World Conference Chat with us , powered by LiveChat Skip to content Chats Contact Speakers Agenda Tickets Menu FULL MENU FULL MENU Register here Rates by JUL. 2 Register here PMWC, Jan 25-27, 2023 PMWC - Silicon valley, ca January 27-29, 2027 Past Event PMWC, Feb 5-7, 2025 PMWC - Silicon valley, ca January 27-29, 2027 Attend Program Schedule Sessions Honorees Speakers Company Competition Showcases Travel Venue Sightseeing Reduced Rates Hotel Flights Exhibits + Map Login / My Account Participate REGISTER TO EXHIBIT Prospectus Attendee Breakdown Apply … ogin / My Account Participate Register to Exhibit Prospectus Attendee Breakdown Apply to speak Sponsorship Inquiry GET UPDATES ABOUT Mission Testimonial Past Conferences Past Honorees Past Speakers FAQ CONTACT US Menu agenda speakers exhibits Contact us agenda speakers exhibits Contact us BUY TICKETS SAVE $1351 BY JUL. 2 Menu Item #1 Item #1 PMWC - Silicon valley, ca Jan. 27-29, 2027 Pittsburgh, pa sep. 23-24 PMWC - Silicon valley, ca Jan. 27-29, 2027 Register Here Rates by J … tend Program Speakers Travel Exhibits + Map Main Program View your save program Award Reception Speaker gallery Select part speakers Exhibit gallery Part conferences Participate Register to Exhibit Apply to speak Sponsorship Inquiry ABOUT Login / My Account CONTACT US Get Updates Pittsburgh, pa sep. 23-24 Register Here Rates by Attend Program Travel Reduced Rates Exhibits + Map Main Program View your save program Award Reception Paticipate Register to Exibit Apply to speak Sp … nomix Labs Alphaexpeditions Alpine Alquest Therapeutics ALS Emergency Treatment Fund Alta Bates Summit Comprehensive Cancer Center Alta Devices AltaQ Altered Egos Comics AltheaDx Althia Altiora Altis Biosystems, LLC Altoida Inc Altos Labs AltruBio Altum Medical Alum Alumot – sprint Aluna Health Alva10 Alveo Technologies Alverno Laboratories AlwaysRx Alykomed Global Solutions LLC Alykomedglobal Alzheimer’s X Alzheon AMA Ama-Assn Amaro Therapeutics Amazon Amber Health Amb … Y Ancestry Anderson Cancer Center Andreessen Horowitz Andrew Andy Strouse Angel Fund Angel Investor ANGLE Biosciences ANGLE Europe Ltd. ANGLE, plc Angleplc Angstrom Bio Angular Medicine Anima AnjaGen Consulting Anl Annai Systems, Inc Annexon Biosciences Annexon Inc Annexonbio Anocca Ansun Biopharma Antenna Anthem Anthony Pastena, M.D. ,P.C Anthos
Diagnosing Memory Loss Before Symptoms Appear 5-STAR SECRET: Why top MA plans prioritize cognitive screening. Borrow their strategy! --> Products Science Customers Payers Providers More About us Blog News Patient education From the CEO , Prevention Diagnosing Memory Loss Before Symptoms Appear Neurotrack CEO, Elli Kaplan, shares the family story behind her mission to prevent memory loss. Elli Kaplan Published on February 27, 2017 4 min read In December of 2004, as my abdomen was sliced open and my son lifted into the world, my grandmother — lying in a hospital room just a few miles away — took
Checking your browser - reCAPTCHA Checking your browser before accessing pmc.ncbi.nlm.nih.gov ... Click here if you are not automatically redirected after 5 seconds.
ICYMI: Joanna Strober sat down with Elli Kaplan, CEO & Founder of Neurotrack, for a powerful live discussion on longevity and brain health 🧠. They covered a wide range of must-know topics… | Midi Health LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any tim
“BACK TO BRAAK”: ROLE OF NUCLEUS REUNIENS AND SUBCORTICAL PATHWAYS IN ALZHEIMER’S DISEASE PROGRESSION • The Journal of Prevention of Alzheimer's Disease Submit online Instructions for authors Past issues Current issue Editorial board About the journal CTAD 2026 Home IF 2025 : 6.7 AND option OR option “BACK TO BRAAK”: ROLE OF NUCLEUS REUNIENS AND SUBCORTICAL PATHWAYS IN ALZHEIMER’S DISEASE PROGRESSION S. Censi 1,2 , C. Sestieri 1,2 , M. Punzi 1 , A. Delli Pizzi 2,3 , A. Ferretti 1,2,4 , F. Gambi 1 , V. Tomassini 1,2,5 , S. Delli Pizzi 1,6 , S.L. Sensi 1,2,5,6 for the Alzheimer’s Dis … zheimer’s Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defense award number W81XWH-12-2-0012). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from AbbVie, Alzheimer’s Association, Alzheimer’s Drug Discovery Foundation, Araclon Biotech, and BioClinica. Inc.; Biogen; Bristol-Myers Squibb Company; CereSpi … tement: Valentina Tomassini has received honoraria, travel grants, and research grant support from FISM, the Italian Ministry of Health, Alexion, Roche, Merck, Biogen, Novartis, Viatris, Bristol Myers Squibb, Almirall, Horizon, Lundbeck, Sanofi, Janssen. Ethical standards: ADNI obtained all IRB approvals and met all ethical standards in the collection of data. The following are the ethics committees and IRB boards that provided approval. Open Access: This article is distribut
Neurotrack Raises $21M in Series C Funding - BioSpace News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events Jobs Companies Hotbeds More Reports Career Advice NextGen: Top Startups to Watch 40 Under 40 Best Places to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event SUBSCRIBE Menu SUBSCRIBE Show Search News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & … laces to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event Search Query Submit Search News Deals Neurotrack Raises $21M in Series C Funding June 11, 2019 | 6 min read Twitter LinkedIn Facebook Email Print Continued growth of Alzheimer’s rates around the world, and increased interest among adults looking to lower risk, driving novel partnerships to lower prevalence in global markets Continue … es over $3.5M in grants from the National Institutes of Health and a fast-track grant worth up to $3.3 million from the National Institute on Aging.* The new investment will be used to advance the company's mission to change how people manage their cognitive health, drive adoption of its Memory Health Program, and continue development and partnerships in global markets. Neurotrack's Memory Health Program is a game-changer in the fight against Alzheimer's. With an estimated 50 … derlying technology, and in 2019, the company was the recipient of a fast-track grant worth up to $3.3 million from the National Institute on Aging. About Neurotrack Neurotrack is building the digital memory health platform of the future, giving people direct access to digital tools and technology to assess, preserve, and strengthen their memory health. The company was co-founded in 2012 by CEO Elli Kaplan , and leading neuroscientists and researchers Stuart Zola , PhD, Eliza … bsp; 2 min read · Tristan Manalac Podcast AbbVie keeps M&A rolling, FDA’s reversal train chugs along, BIO 2026 dispatch, more June 24, 2026 · 1 min read · Jef Akst BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect inn
Neurotrack Digital Therapeutics Study Finds Certain Lifestyle Changes Can Improve Cognitive Function in Older Adults At Risk for Dementia - BioSpace News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events Jobs Companies Hotbeds More Reports Career Advice NextGen: Top Startups to Watch 40 Under 40 Best Places to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event SUBSCRIBE Menu SUBSCRIBE Show Search News Drug Development FDA Manufacturi … laces to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event Search Query Submit Search Biotech Bay Neurotrack Digital Therapeutics Study Finds Certain Lifestyle Changes Can Improve Cognitive Function in Older Adults At Risk for Dementia November 29, 2018 | 5 min read Twitter LinkedIn Facebook Email Print Company Grows Executive Team and Appoints Neil Rothstein, Formerly of 23AndMe and Netflix, as Chief Co … Policy RSS Feeds Advertise Employer Login Post Jobs Talent Solutions Advertise Submit a Press Release Submit an Event © 1985 - 2026 BioSpace.com. All rights reserved. twitter instagram facebook linkedin
Neurotrack Secures $6.5 Million In Financing To Advance Cognitive Health - BioSpace News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events Jobs Companies Hotbeds More Reports Career Advice NextGen: Top Startups to Watch 40 Under 40 Best Places to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event SUBSCRIBE Menu SUBSCRIBE Show Search News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinion … laces to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event Search Query Submit Search Biotech Bay Neurotrack Secures $6.5 Million In Financing To Advance Cognitive Health January 27, 2016 | 4 min read Twitter LinkedIn Facebook Email Print Health company unveils a cognitive health program and new funding PALO ALTO, Calif.--( BUSINESS WIRE )--Today, Neurotrack has announced the release of its first product … in new funding led by Khosla Ventures and supported by Social Capital, Founders Fund, AME Cloud Ventures and iSeed Ventures. The funding will be used to accelerate research, product development, and recruiting and brings the total amount raised to $9.5 million. Neurotrack’s Imprint ™ Cognitive Assessment Test and Cognitive Health Program Imprint™, the Neurotrack test, is a 5-minute web-based test that utilizes eye tracking technology to assess recognition memory and hippocamp … Policy RSS Feeds Advertise Employer Login Post Jobs Talent Solutions Advertise Submit a Press Release Submit an Event © 1985 - 2026 BioSpace.com. All rights reserved. twitter instagram facebook linkedin
Sozo Ventures – Backing pioneers to navigate breakthrough markets Team Portfolio Media Careers Team Portfolio Media Careers Backing Pioneers to Breakthrough Global Markets Learn more Scroll down --> Portfolio NASDQ:ZM NYSE:TWTR NASDQ:COIN Freight Forwarder NYSE:SQ NYSE:PLTR NYSE:FSLY NASDAQ:MDB NYSE:OPWR Acquired by GE Acquired by Fidelis Cybersecurity Acquired by ZoomInfo Acquired by Shopify AI Agent Cloud GPU Provider Cybersecurity Streaming data lake platform Autonomous Surface Vessels Maintenance Management Clean Hydrogen & Graphite Text Marketing Social gaming Supply Chain Mana
Design of optimal nonlinear network controllers for Alzheimer's disease | PLOS Computational Biology Skip to main content Advertisement PLOS Computational Biology Browse Current Issue Journal Archive Collections Find and Read Articles Publish Submissions Getting Started Submission Guidelines Figures Tables Supporting Information LaTeX Other Article Types Preprints Revising Your Manuscript Submit Now Policies Best Practices in Research Reporting Human Subjects Research Animal Research Competing Interests Disclosure of Funding Sources Licenses and Copyright Data Availability Code Availability Co … for access to the data; access to the ADNI data is available through an online application, which can be submitted at the following link: http://adni.loni.usc.edu/data-samples/access-data/ . See S1 Table and S2 Table for more information about the study participants. Funding: LMSR acknowledges support from the Biomedical Engineering Graduate Program at the University of Calgary and the NSERC CREATE I3T Program. YIM is funded by a Banting postdoctoral fellowship (Government o … postdoctoral fellowship (Government of Canada). SCM is funded by a predoctoral fellowship from the Spanish Ministry of Economy and Competitiveness (BES-2015-071253). Data collection and sharing for this project was funded by the Alzheimer’s Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defense award number W81XWH-12-2-0012). ADNI is funded by the National Institute on Aging, the National Institute of Bio … ingly noisier components. Together, these works indicate the feasibility of our proposal in terms of designing a device that delivers tailored signals to any location in the brain. We predict an eventual merging of our theoretical approach with cutting-edge stimulation technology like the ones proposed in the referred studies. Another issue regarding the future development of optimal nonlinear network control of AD is the possibility of the spilling of stimulation to adjacent … cality of brain stimulation techniques might be an advantage for their clinical application [ 49 ]. Several of the regions from which the desired trajectory was achieved at low energetic cost in our model have physical proximity (see Fig 3B and 3D ), and could be reached in a target-specific experiment [ 48 ]. We hypothesize that simultaneous sti
MATTER 2022 Year in Review | Startup funding, health equity & corporate innovation --> Learn more about Paratus — the BARDA Accelerator Network Hub for Digital Health. Click to explore opportunities... Learn more about Paratus — the BARDA Accelerator Network Hub for Digital Health. Click to explore opportunities... Log in to our member portal Startups Corporations Investors Insights Events Home Startups Overview Challenges Our startups Flex Select Corporations Overview Challenges Our partners Join Investors Overview Investor network Insights Blog Podcast Subscribe Events Overview Challenges Ou … nd place and $5,000 and AROMA Sensory & Diagnostics won the audience choice award. Addressing health equity 2022 was our first year partnering with CareQuest Innovation Partners to build SMILE Health , — a program designed to improve health by improving oral health, especially in underserved populations. Five oral health startups ran validation studies with key partners such as Colgate and Cigna, and Lenny Kravitz made a guest appearance at demo day to share the importanc … el Health’s fully recyclable and compostable medication packaging won the grand prize of $35,000. MATTER hosted 11 large-scale innovation challenges. Canada-Chicago Mentoring Program (C2MP) Mentoring and guiding Canadian startups with U.S. market entry and growth Read more KOSME U.S. Market Entry Program Helping Korean small- and medium-sized enterprises with U.S. market entry and growth Read more AWS Expand Preparing EMEA-based startups for U.S. entry and growth Read more 51
Device-Embedded Cameras for Eye Tracking-Based Cognitive Assessment: Implications for Teleneuropsychology Device-Embedded Cameras for Eye Tracking-Based Cognitive Assessment: Implications for Teleneuropsychology Telemed J E Health . 2020 Apr;26(4):477-481. doi: 10.1089/tmj.2019.0039. Epub 2019 Jun 4. Authors Nicholas T Bott 1 2 3 , Erica N Madero 1 , Jordan M Glenn 1 , Alex R Lange 1 , John J Anderson 1 , Doug O Newton 1 , Adam H Brennan 1 , Elizabeth A Buffalo 1 4 , Dor
List of 73 Eye Tracking Startups in US & Canada & Market Trends (May 2026) - Tracxn JavaScript is disabled in your browser. enable it to enjoy the full features of Tracxn. Your browser was unable to load all of Tracxn resources. They may have been blocked by your firewall, proxy or browser configuration. Press Ctrl+F5 or Ctrl+Shift+R to have your browser try again and if that doesn't work, click here to retry or mail us at [email protected] Internal Server Error Toggle navigation Customers Investment Industry Venture Capital Funds Private Equity Funds Accelerators & Incubators Inv … can track user's eye even in motion, and eye tracking solutions which are application-specific to various industries like the automotive industry, healthcare, and market research are included in this sector. Companies which manufacture cameras like webcams, sensor manufacturers, consumer electronics companies which integrate eye tracking into their devices, and resellers and distributors of eye tracking solutions are excluded. Key Metrics Total Companies 73 Top Companie … vestors : NIH , Carnegie Mellon University and 2 Other s Latest Funding Round : Grant (prize money), Apr 06, 2022 , $ ***** Tracxn Score : 48 /100 What is this? Competitors Rank : 8 of 202 Competitors 4 . Blink AI-based eye-tracking technology and software solutions provider. Its solution is software-driven and can be deployed on myltiple camera, running off operating systems. Key facts about Blink Founded Year : 2018 Location : Palo Alto ( United States ) Stage : Series A To … rms and headsets. Its products include a VR creation and collaboration tool, an application development platform, and a patented VR system for professionals. It mainly caters to product design, academic research and architecture, engineering, and construction applications. Key facts about WorldViz Founded Year : 2002 Location : Santa Barbara ( United States ) Stage : Series A Total Funding till date : $6.24M Investors : Intel , Entrada Ventures and 4 Other s Latest Funding Ro
NantWorks Carreras | Levels.fyi Descargar App Cambiar Iniciar Sesión Registrarse Todos los Datos Por Ubicación Por Empresa Por Puesto Calculadora de Salarios Visualizaciones de Gráficos Salarios Verificados Pasantías Salarios H-1B Soporte de Negociación Comparar Beneficios Quién Está Contratando Reporte de Salarios 2025 Empresas que Mejor Pagan Integrar Blog Prensa Google Ingeniero de Software Gerente de Producto Área de Nueva York Científico de Datos Explorar por Diferentes Puestos Levels FYI Logo Salarios 📂 Todos los Datos 🌎 Por Ubicación 🏢 Por Empresa 🖋 Por Puesto 🏭️ Por Industria 📍 M
Neurotrack raises $10m, launches 3-minute cognitive screening test Skip to content News Data Podcast Clinics News Data Podcast Clinics Search Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Advertise NEWSLETTER News Data Podcast Clinics News Data Podcast Clinics Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire About Contact About Contact Advertise nEWSLETTER Search Search DiamiR, AlzLabs team up to … th education and health coaching on cognition and cognitive risk factors, using grant funds from the National Institute on Aging. Preliminary results show significant reduction in symptoms after one year of intervention: thinking and memory improve, and depression and anxiety lessen. Neurotrack recently secured $10 million in new funding to support and accelerate its successful go-to-market push with leading health systems and providers across the US and to continue the devel
Summit Health Ventures Portfolio Companies & Investment Focus | InvestorMatch.pro Investor Match How It Works Pricing Explore Investors For Investors Blog About VC Firms Summit Health Ventures SU Summit Health Ventures VC New York, NY Website How to approach: warm intro preferred Start a Campaign Explore Similar Investors Stage seed+, Series A Check Size $1.0M – $5.0M Portfolio 31+ companies Team 11 partners Investor activity Investments in last 12 months: 0 Investment Thesis Invests exclusively in health technologies with high regulatory barriers and AI/ML applications for patient monitor … Systems JB Jennifer Bish Finance Director TA Timothy Amin Director of Pharmacy Residency Program KL Karen Lichtenberger Director of Revenue Cycle Management SS Stephanie Scotto Director of Marketing MM Maria Mendez Director of Human Resources KC Krina Christian Vice President of Laboratory IT EN Erica Newton Associate Director of Operations MK Mitchell Kotler Partner DL Dr. Laura Evans General Partner Digital Health AI/ML Industry Focus Invests In Healthcare AI / ML Other Po … ennifer Bish — Finance Director Timothy Amin — Director of Pharmacy Residency Program Karen Lichtenberger — Director of Revenue Cycle Management Stephanie Scotto — Director of Marketing Maria Mendez — Director of Human Resources Krina Christian — Vice President of Laboratory IT Erica Newton — Associate Director of Operations Mitchell Kotler — Partner Dr. Laura Evans — General Partner Portfolio Companies NeuroTrack (Digital
Cognitive Health Assessments - ESP on CB Insights Technology Vendors Recent Research Newsletter Media Support Login Who We Serve Function Corporate Strategy Corporate Venture Capital Venture Capital IT Corporate Innovation How VCs Use CB Insights Go to the video gallery → Industries Consumer & Retail Tech Insurance Healthcare Industrials Financial Services Professional Services Professional Services Learn More → Success Stories How We Help Understand Tech Markets Anticipate Competitor Strategy Determine Tech Strategy Connect with Tech Vendors & Partners Turbocharge Digital Transformati
Neurotrack AI: How to Optimize Logistics with AI | Neurotrack.tech posted on the topic | LinkedIn LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, you agree to
Neurotrack Raises $21M for Digital Cognitive Health Platform - Skip to main content Skip to secondary menu Skip to primary sidebar Skip to secondary sidebar Skip to footer Opinion Health IT Behavioral Health Care Coordination EMR/EHR Interoperability Patient Engagement Population Health Management Revenue Cycle Management Social Determinants of Health Digital Health AI Blockchain Precision Medicine Telehealth Wearables Life Sciences Investments M&A Value-based Care Accountable Care (ACOs) Medicare Advantage Neurotrack Raises $21M for Digital Cognitive Health Platform by Jasmine Pennic 06/ … Consultant Latest insightful articles delivered straight to your inbox weekly. Submit a Tip or Pitch Featured Insights Aligning IT & Clinical Teams: How to Reduce Friction and Improve Communication Most-Read Clinical Data Fidelity: The Real Blindspot in Healthcare AI Strategy KLAS 2026 EHR Market Share Report: Epic Gains as Oracle Health Faces Third Year of Losses M&A: Qualtrics Completes $6.75B Acquisition of Press Ganey Forsta Viz.ai Launches Viz Pulmonary™ Suite
News roundup: WakeMed sued on Meta Pixel; Hint Health buys AeroDPC; Neurotrack’s $10M raise, 3 min. cognitive tool intro; layoffs dim Kry, Brightline | Telehealth and Telecare Aware Latest News Perspectives Events Events – Reports Events – old Opinion Soapbox articles Terminology items What are we talking about? What is Telecare? About Donna Cusano: Editor in Chief TTA Policies Advertising Steve Hards: Founder Alerts emails Sign up for our weekly alerts emails - the easiest way to keep up to date! Search for: News roundup: WakeMed sued on Meta Pixel; Hint Health buys AeroDPC;
As Alzheimer's costs soar, startups like Neurotrack raise cash to diagnose and treat the disease | TechCrunch –:–:–:– The first StrictlyVC of 2026 hits SF on April 30. Tickets are going fast. Register now. Founder Summit ticket savings of up to $190 end June 26. Join 1,000+ founders and VCs for all-day bootcamp. REGISTER NOW. Close TechCrunch Desktop Logo TechCrunch Mobile Logo Latest Startups Venture Apple Security AI Apps Disrupt 2026 Events Podcasts Newsletters Search Submit Site Search Toggle Mega Menu Toggle Topics Latest AI Amazon Apps Biotech & Health Cl
Neurotrack Raises $2 Million Series A Led by Founders Fund - BioSpace News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events Jobs Companies Hotbeds More Reports Career Advice NextGen: Top Startups to Watch 40 Under 40 Best Places to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event SUBSCRIBE Menu SUBSCRIBE Show Search News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releas … laces to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event Search Query Submit Search Biotech Bay Neurotrack Raises $2 Million Series A Led by Founders Fund September 26, 2013 | 5 min read Twitter LinkedIn Facebook Email Print PALO ALTO, CA--(Marketwired - September 26, 2013) - Neurotrack , an emerging leader in the development of behavioral biomarkers to assist with the diagnosis of Alzheimer's disease, … sease, today announced that it has raised a $2 million Series A led by Founders Fund and joined by The Social+Capital Partnership and several angel investors. The funds will be used to further develop and commercialize the company's breakthrough technology, a visual cognitive test sensitive to damage in brain regions first impacted by Alzheimer's disease. An NIH-sponsored longitudinal study demonstrated that the test may help predict the cognitive decline associated with Alzh … Thiel, the well-known entrepreneur and investor -- and the founder of Founders Fund. "We need new thinking and new approaches to get around the road blocks that have been holding back the diagnosis and treatment of Alzheimer's. By bringing disruptive technology to a long-standing medical issue, I believe Neurotrack will be able to make rapid gains in the fight against this disease." Today there is no single technology that can provide a definitive pre-symptomatic diagnosis o … Mild Cognitive Impairment and Alzheimer's Disease", 28:2, 2013). About Founders Fund Founders Fund is a venture capital firm in San Francisco that provides capital to transformational businesses run by world-class entrepreneurs. Companies the firm has backed include Facebook (managing partner Peter Thiel was Facebook's first outside backer), Spac
Careers at Neurotrack: Work to Improve Brain Health | Neurotrack LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement , Priv … ortunities to the sales team. You turn the outreach into meetings for the team. Apply now and be a part of the future of Alzheimer’s care at Neurotrack: https://lnkd.in/eq5qNzZj #Hiring #BusinessDevelopment #Healthcare #AlzheimersCare #Neurotrack #JoinOurTeam #MissionDriven Careers at Neurotrack: Work to Improve Brain Health neurotrack.com 9 Like Comment Share Copy LinkedIn Facebook X To view or add a comment, sign in 6,715 followers View Profile Follow Explore content catego
Product Manager @ Neurotrack | Khosla Ventures Job Board Menu Close About Portfolio Team Current Learn [email protected] [email protected] 2128 Sand Hill Road Menlo Park, CA 94025 (650) 376.8500 People Matter Join the teams that make the Impossible Happen. Search jobs Explore companies Join talent network Talent My job alerts Product Manager Neurotrack This job is no longer accepting applications See open jobs at Neurotrack . See open jobs similar to " Product Manager " Khosla Ventures . Product Canada · Remote Posted 6+ months ago Position: Product Manager Location: Canad … connection : Engage with customers to see firsthand the impact of your product. Apply for this Position This job is no longer accepting applications See open jobs at Neurotrack . See open jobs similar to " Product Manager " Khosla Ventures . See more open positions at Neurotrack Powered by Getro.com Privacy policy Cookie policy [email protected] [email protected] 2128 Sand Hill Road Menlo Park, CA 94025 (650) 376.8500 Separate valuation from value. Privac
In-Home Dementia Screening Delivers Clinical Benefits While Expanding Patient Service Pathways - Home Health Care News Continue to Site Skip to content Resources White Papers, Ebooks, Reports & Briefs Voices Views Series Event Q&As Events Virtual Events Live Events Elevate Capital + Strategy Forum PAYER Summit FUTURE Conference Podcast Awards Webinars HHCN+ Advertising Subscribe Search for: Search Submit Go Compliance Fraud Legislation Regulation Finance M&A Private Equity Startup Operations Franchises Sales & Marketing Staffing Technology Reimbursement Medicaid Medicare Ad … Care Hospice Palliative Care Personal Home Care Toggle Menu Search for: Search Submit Go Compliance Fraud Legislation Regulation Finance M&A Private Equity Startup Operations Franchises Sales & Marketing Staffing Technology Reimbursement Medicaid Medicare Advantage Medicare CMS Service Types Home Health Care Hospice Palliative Care Personal Home Care Reports Jobs Podcast Awards Subscribe AartlistDesign/Pixabay | CC0 Home Health Care In-Home Dementia Screening Deliv
AI solutions for business – about Neurotrack Home About us Cases Services AI Chatbot Development AI Voice Assistant AI Employee Onboarding AI Meeting Assistant Development Services Blog Partners Contacts English Polski Español Українська Portuguese English UK Leave a request Leave a request About us AI solutions for business Neurotrack.tech is a Ukrainian company specializing in the development of advanced AI solutions for business automation and process optimization. We help companies increase efficiency, reduce costs, and improve customer interactions through intelligent technologies. Our so … a free consultation to identify your needs and select the optimal AI solution . Submit a request, and our experts will contact you shortly. Submit a request Innovation and efficiency with Neurotrack 40 Developed AI solutions for business automation 80 Reduction of costs and time thanks to our technologies Neurotrack is a team of experts in artificial intelligence and automation, developing solutions aimed at enhancing your business efficiency. We create intelligent AI solutio
Frontiers | The efficacy and practicality of the Neurotrack Cognitive Battery assessment for utilization in clinical settings for the identification of cognitive decline in an older Japanese population Frontiers in Aging Neuroscience About us About us Who we are Mission and values History Leadership Awards Impact and progress Frontiers' impact Our annual reports Thought leadership Publishing model How we publish Open access Quality and research integrity Peer review Research Topics Publish your data Fee policy Services Societies National consortia Institutional partnerships Collaborators M … partnerships Collaborators More from Frontiers Frontiers Forum Frontiers Planet Prize Press office Sustainability Career opportunities Contact us All journals All articles Submit your research Search Frontiers in Aging Neuroscience Sections Sections Aging Neuroscience Archive Alzheimer's Disease and Related Dementias Cellular and Molecular Mechanisms of Brain-aging Neurocognitive Aging and Behavior Neuroinflammation and Neuropathy Parkinson’s Disease and Aging-related Mov … rnal sections Open access statement Copyright statement Quality For authors Why submit? Article types Author guidelines Editor guidelines Publishing fees Submission checklist Contact editorial office About us About us Who we are Mission and values History Leadership Awards Impact and progress Frontiers' impact Our annual reports Thought leadership Publishing model How we publish Open access Quality and research integrity Peer review Research Topics Publish your data Fee p … partnerships Collaborators More from Frontiers Frontiers Forum Frontiers Planet Prize Press office Sustainability Career opportunities Contact us All journals All articles Submit your research Frontiers in Aging Neuroscience Sections Sections Aging Neuroscience Archive Alzheimer's Disease and Related Dementias Cellular and Molecular Mechanisms of Brain-aging Neurocognitive Aging and Behavior Neuroinflammation and Neuropathy Parkinson’s Disease and Aging-related Movement D … rnal sections Open access statement Copyright statement Quality For authors Why submit? Article types Author guidelines Editor guidelines Publishing fees Submission checklist Contact editorial office Frontiers in Aging Neuroscience Sections Sections Aging Neuroscience Archive Alzheimer's Disease and Related Dementias Cellular and Molecular Me
Elli Kaplan of Neurotrack - Product in Healthtech | Podcast on Spotify
Elli Kaplan | Co-founder and CEO - Neurotrack | Forbes Technology Council Log in Do I Qualify? Do I Qualify? Person Elli Kaplan Co-founder and CEO Neurotrack San Francisco Bay Area LinkedIn About Elli Kaplan is the co-founder and CEO of Neurotrack, a Silicon Valley-based digital health company on a mission to transform the diagnosis and prevention of memory loss and related diseases like Alzheimer's. Ms. Kaplan is passionate about using technology to advance social change for good, creating solutions that have meaningful impact on their customers and the world. With significant experience … capital firms including Sozo Ventures, Marc Benioff, Khosla Ventures, Founders Fund, Social Capital, AME Cloud Partners and Rethink Impact, as well as strategic investments from Japanese insurance leaders, Dai-ichi Life and SOMPO Holdings. In 2019, it was the recipient of a SBIR fast-track grant worth up to $3.3 million from the National Institute on Aging, and the company’s scientific co-founders have raised over $7M in NIH grants to conduct research into its underlying tec
- YouTube Info Presse Urheberrecht Kontakt Creator Werben Entwickler Impressum Verträge hier kündigen Nutzungsbedingungen Datenschutz Richtlinien & Sicherheit Wie funktioniert YouTube? Neue Funktionen testen © 2026 Google LLC
Detecting Dementia with Neurotrack's Solutions | Elli Kaplan posted on the topic | LinkedIn LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, you agree to L
Elli Kaplan, Author at MedCity News Twitter Facebook TikTok YouTube LinkedIn RSS Subscribe via email Newsletter Signup Send Tips Webinars eBooks Open navigation MedCity News Toggle Search Close navigation News Health Tech BioPharma Devices & Diagnostics Consumer / Employer Contributors MedCity Influencers Events Bullseye INVEST Digital Health Podcasts Research Newsletters Newsletter Signup Send Tips Webinars eBooks Twitter Facebook TikTok YouTube LinkedIn RSS Subscribe via email Search for: Search Elli Kaplan Elli Kaplan is the co-founder and CEO of Neurotrack , a digital health company fo
Jobs - Rethink Impact Home About Us Investments Jobs News Open Letter Investors Contact Us Rethink Impact Home About Us Investments Jobs News Open Letter Investors Contact Us Jobs Openings at our portfolio companies Close Enter your text here Interested in helping to change the world in your job? Many of our portfolio companies are hiring. You can find the openings below with links to the longer descriptions/applications. To apply for any of these jobs, click the link and apply directly through the company’s website (as opposed to coming through us). Aclima Angaza Binti Bold Candidly Car
MATTER startup shoutouts: Winter 2023-24 --> Learn more about Paratus — the BARDA Accelerator Network Hub for Digital Health. Click to explore opportunities... Learn more about Paratus — the BARDA Accelerator Network Hub for Digital Health. Click to explore opportunities... Log in to our member portal Startups Corporations Investors Insights Events Home Startups Overview Challenges Our startups Flex Select Corporations Overview Challenges Our partners Join Investors Overview Investor network Insights Blog Podcast Subscribe Events Overview Challenges Our startups Flex Select Overview Challenges … ups received strategic investments or completed raises. Acorai received a $2.3M grant. Acorai received a €2.3m grant, with a follow-on €10m investment offer, from the European Innovation Council. Augment Therapy raised a $2.7M Seed Plus round to support the company’s growth. Augment Therapy, a digital health company enhancing rehabilitative healthcare through immersive and gamified technology, raised a $2.7M Seed Plus round to support the company’s growth, continue research v … ,000 at ventureLAB’s Third Annual Hard Tech Summit. CARI Health awarded a $2.8M grant to develop an innovative remote medication monitoring device. CARI Health was awarded a $2.8M SBIR grant from the National Institutes on Drug Abuse to develop their novel remote medication monitoring device. DINA receives strategic investment from SCAN Group. Dina received a strategic investment from the SCAN Group, one of the nation’s largest not-for-profit Medicare Advantage plans. Enhance … bscribed pre-Series A round with support from dsm-firmenich venturing, The Kale Fund, Keiretsu Forum and angel investors. Medipixel announces completion of $12.5M Series. Medipixel announced completing a $12.5M Series B with participation from Premier Partners, Company K Partners, IMM Investment, SBI Investment, Industrial Bank of Korea, Quad Asset Management and Daily Partners. Partum Health raises $3.1M Seed round, expanding access to pregnancy and postpartum care services. … xpand access to pregnancy and postpartum care services. Rhaeos receives a $1.5M grant through their Blueprint MedTech program. Rhaeos received a $1.5M grant from the National Institutes of Health’s National Institute of Neurological Disorders and Stroke through their Blueprint MedTech program. Xploro secures investor for 1.7M Seed round. Xploro s
Ideas we’d like to fund | Rock Health Advisory Capital RockHealth.org INSIGHTS For Entrepreneurs February 25, 2013 Ideas we’d like to fund Applications for Rock Health’s fifth class are open ! You bring the startup, and we’ll provide the funding ($100K), strategic partnerships, and operational support to help you succeed. What do we look for? Big ideas backed by smart and driven entrepreneurs, with a sustainable and scalable business model. Here are just a few ideas we’d like to see: Chronic disease management : Chronic conditions account for 75% of health spending in the Unites States. … lkanized, archaic industry. We’re not looking for incremental ideas that simply apply modern technology to minor problems. This isn’t about apps, social networks, or the cloud. We want to solve the biggest problems in healthcare. We want ideas that can reduce system costs by 50%, eliminate medical errors (all of them), cure or prevent diseases, make everyone of us a doctor, cut the time it takes to bring a new therapy (digital or molecule) to market in half, and measure and r … second basis. So if you’re crazy enough to try, we want to hear from you. APPLY NOW Advisory Capital RockHealth.org Privacy Policy © ROCKHEALTH 2022
The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians ( Open Payments ) Insights from patie … Patents, Royalties, Other Intellectual Property - Manta Cares Inc has a patent application where I am listed as a key inventor. Other Relationship - Mercy Bioanalytics; Neurotrack; Sozo Ventures Megan Hartranft Employment - LabCorp; Sanofi Stock and Other Ownership Interests - LabCorp; Sanofi Consulting or Advisory Role - Manta Cares Erin Landis Consulting or Advisory Role - Manta Cares Travel, Accommodations, Expenses - Manta Cares Josh Carter Consulting or Advisory Role - … s; LucidAct; MantaCare Patents, Royalties, Other Intellectual Property - Patent application submitted 5/2023 with Samira Daswani for Cancer Maps Travel, Accommodations, Expenses - Manta Cares
The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians ( Open Payments ) Qualitative accepta … Patents, Royalties, Other Intellectual Property - Manta Cares Inc has a patent application where I am listed as a key inventor. Other Relationship - Mercy Bioanalytics; Neurotrack; Neurotrack; Sozo Ventures Molly Lindquist Employment - Consano; Kaiser Permanente (I); Manta Cares; Oregon Anesthesiology Group (I) Leadership - Oregon Anesthesiology Group (I) Stock and Other Ownership Interests - Madorra Consulting or Advisory Role - Manta Cares Travel, Accommodations, Expenses … aCare; TG Therapeutics Patents, Royalties, Other Intellectual Property - Patent application submitted 5/2023 with Samira Daswani for Cancer Maps (OPTIONAL) Uncompensated Relationships - Manta Cares
The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians ( Open Payments ) Clinical utility an … Patents, Royalties, Other Intellectual Property - Manta Cares Inc has a patent application where I am listed as a key inventor. Other Relationship - Mercy Bioanalytics; Neurotrack; Neurotrack; Sozo Ventures Bellinda King-Kallimanis Honoraria - Emerson Collective; Health Outcomes Solutions; University of South Florida Consulting or Advisory Role - Abbvie; Adelphi; Lilly; Shionogi Research Funding - AstraZeneca (Inst); Blueprint Medicines (Inst); Bristol-Myers Squibb/Roche (In … - LucidAct; MantaCare Patents, Royalties, Other Intellectual Property - Patent application submitted 5/2023 with Samira Daswani for Cancer Maps Travel, Accommodations, Expenses - Manta Cares
The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians ( Open Payments ) Acceptance and usab … Patents, Royalties, Other Intellectual Property - Manta Cares Inc has a patent application where I am listed as a key inventor. Other Relationship - Mercy Bioanalytics; Neurotrack; Neurotrack; Sozo Ventures Douglas W. Blayney Leadership - Artelo Biosciences Stock and Other Ownership Interests - Artelo Biosciences; Madorra; MantaCare Consulting or Advisory Role - BeyondSpring Pharmaceuticals; EMBOLD Health; Laboratoire HRA Pharma; Lilly; MantaCare; TG Therapeutics Patents, Ro … aCare; TG Therapeutics Patents, Royalties, Other Intellectual Property - Patent application submitted 5/2023 with Samira Daswani for Cancer Maps (OPTIONAL) Uncompensated Relationships - Manta Cares Molly Lindquist Employment - Consano; Kaiser Permanente (I); Manta Cares; Oregon Anesthesiology Group (I) Leadership - Oregon Anesthesiology Group (I) Stock and Other Ownership Interests - Madorra Consulting or Advisory Role - Manta Cares Travel, Accommodations, Expenses - Manta Ca
#neurorecovery #fatigueinrehab #digitaltherapy #strokerecovery #neurotrack | NeuroTrack LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, you agree to LinkedIn’
Facebook Explore the things you love . Log into Facebook Email or mobile number Password Log in Forgot password? Create new account English (US) فارسی العربية Türkçe Deutsch Français (France) Polski More languages… Sign Up Log In Messenger Facebook Lite Video Meta Pay Meta Store Meta Quest Ray-Ban Meta Meta AI Instagram Threads Privacy Policy Privacy Center About Create ad Create Page Developers Careers Cookies Ad choices Terms Help Contact Uploading & Non-Users Meta © 2026
The State of American Dementia Care in Four Maps 5-STAR SECRET: Why top MA plans prioritize cognitive screening. Borrow their strategy! --> Products Science Customers Payers Providers More About us Blog News Patient education Diagnosis The State of American Dementia Care in Four Maps Regional heat maps reveal gaps, trends, and troubles in dementia detection and ongoing care. Neurotrack Team Published on September 17, 2024 4 min read Location is everything, even when it comes to dementia and Alzheimer's care. In fact, some of the latest research on dementia detection, diagnosis, and treatment u
Digital Health 150 Of 2019: The Digital Health Startups Redefining The Healthcare Industry - CB Insights Research --> AI tools & agents Apps Strategy Terminal Powerful AI-driven discovery, research and insight tools Browser Analyst Personal AI-powered insights on any web page Mobile app Instant insights, in the moment Agents Team of agents Put our agents to work and turn insights into action Features ChatCBI™ Unique insight and data, plus the creativity of generative AI 10M+ companies Data and insight on 10M+ companies 1,500+ markets Data and insight on 1,500+ markets Personal briefing L … ealth, OWKIN, Pill Club Venrock 28 Lyra Health, Devoted Health, Kyruus Founders Fund 27 Emulate, Collective Health, Teckro Khosla Ventures 27 Neurotrack Technologies, SWORD Health, GE Ventures 22 Genome Medical, Evidation Health, Verana Health, Iora Health Social Capital 20 Syapse, Modern Health, Suki, Neurotrack Technologies .406 Ventures 19 Redox, Nomad Health, Bend Financial, AbleTo Andreessen Horowitz 18 Freenome, Omada Health, Ciitizen, Devoted Health Track all th … ficial partner, Wright’s Media, about available usages, license fees, and award seal artwork at [email protected] . Please note that Wright’s Media is the only authorized company that we’ve partnered with for CB Insights materials. If you aren’t already a client, sign up for a free trial to learn more about our platform. Related reports Research areas: Digital Health Future of Health 2019 Healthcare & Life Sciences Related research Related research
This Entrepreneur Aims To Make Cognitive Screening As Easy As Checking Your Pulse Sign Up For Newsletters Games Share a News Tip Featured Featured Breaking News White House Watch Daily Cover Stories 2026 Forbes World's Most Influential CMOs List Making It Their Way: Six TikTok Creators On Finding A High-Quality Content Strategy That Pays Off | Paid Program The Hidden Tax On Enterprise AI: 1 In 5 Workers Lose A Full Day Every Week | Paid Program Scaling AI Editorial Video Series Silicon & Steel Editorial Video Series Turning Pressure Into Progress For Your Small Business | Paid Program … 57 million, with investors including Johnson & Johnson Innovation, Founders Fund, Khosla Ventures and Salesforce cofounder Marc Benioff. Kaplan cofounded Neurotrack in 2012, along with neuroscientists Stuart Zola, Elizabeth Buffalo and Cecelia Manzanares. She was inspired by her own history: two of her grandparents were diagnosed with Alzheimer’s. She was struck, she said, by how difficult it was both to get the initial diagnosis as well as accessing the care needed for s
Welkin Health and Neurotrack Partner on New Study to Advance Solutions for Individuals At Risk for Cognitive Decline – Mobile Health Times Skip to content Search News & Trends by Sector Providers Payers Employers Government & Agencies Pharma & Life Sciences Research Business of Healthcare Strategy & Transformation Revenue and Reimbursement M&A and Finance Partnerships Marketing Workforce & Culture People Innovation & Technology EHRs & Interoperability AI & Machine Learning Telehealth & Remote Care Cybersecurity & Privacy Digital Health Devices … h Times, Host/Founder Power Press Awards LinkedIn Subscribe to Newsletter Email Submit Please enable JavaScript in your browser to submit the form News & Trends by Sector Providers Payers Employers Government & Agencies Pharma & Life Sciences Research Business of Healthcare Strategy & Transformation Revenue and Reimbursement M&A and Finance Partnerships Marketing Workforce & Culture People Innovation & Technology EHRs & Interoperability AI &
Dementia Products from Eugeria Neurotrack and TapRoot’s elbi app Skip to content Advancing Health and Longevity Through Technology Home About Linda Sherman Ray Gordon Rethinking Aging Club Testimonials Disclosures News for the Ages Podcast Rethinking Aging Club Podcast Categories Caregiving Conferences How To Contact Submit Guest Post Dementia Products from Eugeria, Neurotrack and TapRoot’s elbi app June 20, 2025 | Linda Sherman For Other Podcast Platforms please click "share" on any podcast player. Valerie Larochelle of Eugeria highlighted their consumer facing e-commerce platform for vetted,
How digital tools can improve cognitive health assessments | Neurotrack posted on the topic | LinkedIn LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, you agr
Neurotrack Awarded $3.3 Million Grant from National Institute on Aging to Study the Impact of its Cognitive Health Digital Therapeutic 5-STAR SECRET: Why top MA plans prioritize cognitive screening. Borrow their strategy! --> Products Science Customers Payers Providers More About us Blog News Patient education Prevention , Press Release Neurotrack Awarded $3.3 Million Grant from National Institute on Aging to Study the Impact of its Cognitive Health Digital Therapeutic Testing virtual delivery of multi-domain lifestyle interventions via patient education and coaching to reduce risk of Alzheime … of cognition and memory loss, today announced it has been awarded a fast-track grant worth up to $3.3 million, pending the completion of milestones, from the National Institute on Aging (NIA), part of the NIH, to assess how the company’s Memory Health Program, a digital, multi-domain lifestyle intervention, affects memory health in those at risk for Alzheimer’s and related dementias. “We are honored to receive the NIA’s support to conduct this groundbreaking study into what … ain interventions over 12 months with observable improvements in cognition. The grant, awarded through the NIA’s Small Business Innovation Research (SBIR) Seed Fund, will enable Neurotrack to fully evaluate its delivery, use, and impact on improving cognitive health among those at-risk over a two-year period. The company will collaborate with Dr. Michelle Gray at the University of Arkansas Exercise Science Research Center (ESRC) on the study. Dr. Gray and her team have signif … plan, Co-founder and CEO, Neurotrack. “We’re thrilled to have been awarded this grant to continue our work and protect the memories of millions.” This work is supported by the National Institute on Aging of the National Institutes of Health under Award Number 1R44AG063672-01. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Related reading How Medicare V28 Coding Changes May Aff
Neurotrack - Atlanta Magazine News/Culture Arts & Events Great Reads World Cup 2026 Atlanta 500 Women Making A Mark 2025-2026 Independent School Guide Food & Drink 75 Best Restaurants 57 Best Bars Best Cheap Eats 123 Things to Eat on Buford Highway 50 Best Tacos Restaurant Reviews Health Health & Wellness Top Doctors Sponsored: Physician Profiles 2025 Top Dentists Sponsored: Dentist Profiles 2026 Best of Eat Drink Do Buy Readers’ Choice Georgia Design Georgia Design Awards Submissions Georgia Design Digital Editions Artists & Galleries Design Advice Design News Gardens Real E … y Recover your password your email Search Subscribe Sign Up for our Newsletters Submit Your Entries for the 2026 Georgia Design Awards 2026 Atlanta 500 Advertise Contact Us Issue Archive Sign in Welcome! Log into your account your username your password Forgot your password? Get help Create an account Privacy and Cookies Policy Create an account Welcome! Register for an account your email your username A password will be e-mailed to you. Privacy and Cookies Policy Password re
Neurotrack's Digital Cognitive Testing Platform Delights Doctors | Neurotrack posted on the topic | LinkedIn LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign i
Elli Kaplan of Neurotrack–Product in Healthtech – Apple Podcasts Search Home New Top Charts Search 6 July 2023 38 min Elli Kaplan of Neurotrack Product in Healthtech Play Product in Healthtech is community for healthtech product leaders, by product leaders. For more information, and to sign up for our free webinars, visit www.productinhealthtech.com . Neurotrack website: www.neurotrack.com Elli Kaplan https://www.linkedin.com/in/elli-kaplan-ba375b16/ For the full YouTube video: https://youtu.be/tKpz6oXUTTI Product in Healthtech is community for healthtech product leaders, by product lead
Neurotrack Press Releases, Information on Cognitive Test Makers 5-STAR SECRET: Why top MA plans prioritize cognitive screening. Borrow their strategy! --> Products Science Customers Payers Providers More About us Blog News Patient education News about Neurotrack media and events Interviews, panels, and speaking enagements We are passionate about the detection and care of cognitive disease. Reach out to schedule an interview, or invite team members to your conference or event. Contact our communications team Press releases December 2023 3-Minute Online Cognitive Screening Simplifies Nati … n for Cognitive Impairment Read more April 2019 Neurotrack Awarded $3.3 Million Grant from National Institute on Aging to Study the Impact of its Cognitive Health Digital Therapeutic Read more See More Recent coverage and bylines July 2023 Helping Primary Care Teams Catch Cognitive Impairment Early Matter Health Read more July 2023 MedCity Influencers: Covid Is Still With Us: What Does That Mean for Your Brain MedCity News Read more July 2023 MedCity Influencers: Three Things
A New Way To Test For Cognitive Health with Neurotrack’s Elli Kaplan | HOT FLASHES & COOL TOPICS Cancel Home Subscribe Profile HOT FLASHES & COOL TOPICS https://feed.podbean.com/hotflashescooltopics/feed.xml 427.8K Downloads 419 Episodes Share RSS The podcast voice for women 50+. We talk about everything to do with this time of life from relationships and careers, women’s health and wellness to celebrity interviews. New episode every Wednesday. The podcast voice for women 50+. We talk about everything to do with this time of life from relationships and careers, women’s health and wellness … it The “Hot Flashes and Cool Topics” podcast should open on the Apple Podcasts application Keep scrolling on the page until you see “Ratings and Reviews” Click on “See All” If you want to give us a five-star rating, hover over the empty stars! If you want to leave your thoughts and comments, click on “Write a Review”! Likes Share Comment (0) No comments yet. Be the first to say something! Hot Flashes & Cool Topics Podcast Powered By Podbean Version: 20241125
Empowered Patient Podcast: Using Digital Tools to Transform Cognitive Assessment with Elli Kaplan Neurotrack TRANSCRIPT Toggle navigation About Contact Episodes All Episodes Categories Addiction Aging and Seniors Allergies Big Data Big Data and AI Cancer Cardiology CBD Cell Therapy Central Nervous System Clinical AI Clinical Trials COVID-19 Depression Dermatology Diabetes Diagnostics Dietary Supplements Digital Health Doctors Empowering Patients Epigenetics Gastrointestinal Disorders general Gene Therapy Genetics GIS Healthcare Investing Healthcare Protesting Healthcare workers Hospitals Hyper … ith Karen Jagoda is a window into the latest innovations in digital health, the application of AI for administrative and clinical uses, the changing dynamic between doctors and patients, personalized medicine, cell and gene therapies, aging in place, wearables and sensors, clinical trials and advances in clinical research, payer trends, transparency in the medical marketplace and challenges for connected health entrepreneurs. This show continues to evolve driven by the conver
Skip to main content Solutions Services Industries Work Insights Contact Podcast Brought to you by Season 3 • Episode 13 Elli Kaplan of Neurotrack Elli Kaplan - Co-Founder & CEO at Neurotrack YouTube Spotify Apple Podcasts Episode Highlights Timestamp: About this episode Eli discusses how she and her team have built some of the most groundbreaking technology in the cognitive health space and where they see it going from here. In this episode, we cover: Full Transcript Chris Hoyd 0:07 Welcome back to Product in Healthtech, a community for health tech product leaders by product leaders. I'm … ight now, you know, I'd be interested to hear your sort of take on how AI might apply to a solution like neuro tract, is that sort of factor into your roadmap? How do you How are you thinking about that? Elli Kaplan 31:12 Ai factors into everybody's roadmap, one way or another, at least from the perspective of like, is AI something that we should be figuring out how to incorporate? And so yes, it does. And so we think about it from a few different perspectives. One is, can we
Elli Kaplan On Raising $60 Million To Keep Your Mind Sharp And Memory Intact - Alejandro Cremades Bootstrap CSS --> 🚀 Ready to Raise Capital 3X Faster? Start for Free See How It Works PROGRAMS --> FUNDRAISING TOOLS BLOG DEALMAKERS PODCAST BUSINESS TEMPLATES M&A ADVISOR MY STORY FIND INVESTORS NOW 🧠 Still Guessing What Investors Want? StartupFundraising.com uses AI to show you who’s writing checks—then helps you pitch like a pro and close your round 3× faster. Get Funded Faster → . Elli Kaplan On Raising $60 Million To Keep Your Mind Sharp And Memory Intact by Alejandro Cremades Elli Kaplan h
Instagram See everyday moments from your close friends . Log into Instagram Mobile number, username or email Password Log in Forgot password? Log in with Facebook Create new account Meta About Blog Jobs Help API Privacy Terms Locations Popular Instagram Lite Meta AI Threads Contact Uploading & Non-Users Meta Verified English Down chevron icon Afrikaans العربية Čeština Dansk Deutsch Ελληνικά English English (UK) Español (España) Español فارسی Suomi Français עברית Bahasa Indonesia Italiano 日本語 한국어 Bahasa Melayu Norsk Nederlands Polski Português (Brasil) Português (Portugal) Русский Svenska ภ
Privacy Policy 5-STAR SECRET: Why top MA plans prioritize cognitive screening. Borrow their strategy! --> Products Science Customers Payers Providers More About us Blog News Patient education Privacy Policy Last updated March 26, 2025 We at Neurotrack Technologies Inc. (“Neurotrack,” “we,” and “us”) believe you should always know what data we collect from you and how we use it. The purpose of this Privacy Policy is to let you know what kind of information we may gather, why we gather your information, what we use your information for, how you can manage your information, how we protect it, and … red Entities, sponsors, and partners. You may even decide to link a third-party application to your Neurotrack account and share your information with that third party. We are not responsible for the privacy practices or content of these other third-party services. We encourage you to read the privacy statements of each and every website, app, or service you use regardless of whether you access it through our Services. This Privacy Policy applies solely to information we coll
%PDF-1.4 % ���� 4 0 obj > /PageLabels > ] >> /Outlines 2 0 R /Pages 1 0 R >> endobj 5 0 obj > endobj 6 0 obj > >> endobj 7 0 obj > stream x��W�n7& �x*��oDJk��!�d� �I�@m qׇ�ilrR���}�~ܕvie�lG���,93��o�W������ x�q���5�R��oV�α� ����?�ߊ�~�H �{U�����䜥p�V|4���yE���ɍ�jR�� v'�C�K[oD�3cI��{v���O����P��SHK/Gٛ�nJ�Y�s�1����v�՚���ц� ���� |����4����VڑI #�isz�F��:-ߩn�3Q_M���=���:�Ɗ��3{��I6�ذ�l�bO�WD'��(1��S+�#Lx[T�6��H=S���¤X�X������m�W� ?��?�;��ٻ; � ���,����� $#� �3>��.�lMTQ��Y��{�B��%`����g#����� I�h SO��4Wb1/@c��"�5�(C�^�d�q��m4�Z4IA��+%ZI�~���D�T{j�%�C� … sMt�@���y�Ά 볢� ��%�®�x}Ԑ ���랄�ץj�}�0�C!,��� K�'���ݷ���v@�H� 3|�P�;}8�)}RFp�� �n!OOj鴝fo�E!%U�gm�8��߮h��esuǚ��� ���ǃ�Wn&�ȲG�#o�ͅ���g ��e�d*^���p?:�yr��[�p@?*�x�� � �� ڍ�7 $� �t}~f�>���YW#p���\�&� ��?��T,M�d�q�n��LAtb�d�\v;�`���?ZS ��`6��O9�O~s�¾R�r��pP|�v�:�>�Eʅr���ZL`㠭u�rm�"]�z���%ejV�n�o)�UnU��f�>��l�;9 ��$}� ��A�~�$��&�(�d {���;���D�b6��o�r�1��=�8��P����3g?w���Z� js���Px ���z��$/#�� 7\����U"]���t��MdjҲL�q��z�z;� ����.�~�)E9� ? … � a�T��`�eG�-�#8B�*t S�O �F�0�8�ѱ@�������ٌ�ڟu'˅�@�#���~4E1[r2�*9���( RFp@� ��U��"�,[n�d ��>��1����o+�I�7;}ri�### �}ӏ֧}��2v�?���A4�(*��*N�� � �����s�z/�� ���.��Q��$m ܹ=��=22(�̂@�P��y,� ��s�����~Y� ��*+BNyQ�s� ��4^_����_� �=���>�uoQL���' _S����#(X�g=2ç�?Z����`w`?���9nI?x��o>ݩV?������q���i�� �C���s���Ð�'i�9�{�JDb�9RS$�G>��pH ���u�*D!��� p3��9 �P�+4132��p���u ��� @$3�8��_¢B�n�P r���/L� O�)��L�I$��ۜd ��&�34p�S��ӠC� *���F�,K`�V瞃� … � ��,>�~�2��0��j'4�";�M���t6��#�>��Xs� ��_� O ؠ,��� ��^��+}�|�s3� a���iQ�RfP\���E垀QEQEb�(�,(��)�ȱF�9¨$�juej������ N҇�Mc�xn��e18���+����Y!X�n���=��2d�uA���� ����I��U��\����{Q�l�*�I�t�O�-mJ�t|�8��5�QS*�(́p:`v�eN*�ֲLv2$f��*ݵ��8 Y�+��Ȫ�U�0=�\g�&y��G��F�u� z �;��;�7$����q�O�Y�> R�� ê��T+G���A��m��e���T[ȇ�O���h����,k�+.� ��[Fw�F;.5]���AW&��vZ�1�7�aU��jU'�3P��b��6�=BD�b���^{U���� c�R� ���W�?�Oc �s����I^�-��]���* �y>��A�ƃ�*��`�02 ��l��>g�� … ڈ��tP�\|�M��M.��I� �I�z���Z�����wp�Q�� ���Q@�2�# ��l~ �f�J��`��� ��RFp@�ֺ�(��~���\�����˒B��|�+�-����X�A�QF �%QEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQ
%PDF-1.4 %���� 19705 0 obj > endobj xref 19705 60 0000000016 00000 n 0000004695 00000 n 0000004859 00000 n 0000005972 00000 n 0000006025 00000 n 0000006078 00000 n 0000006132 00000 n 0000006248 00000 n 0000012992 00000 n 0000019598 00000 n 0000026177 00000 n 0000026376 00000 n 0000026816 00000 n 0000033883 00000 n 0000042368 00000 n 0000050505 00000 n 0000050860 00000 n 0000051260 00000 n 0000052011 00000 n 0000052873 00000 n 0000053624 00000 n 0000053881 00000 n 0000054536 00000 n 0000054650 00000 n 0000054913 00000 n 0000055552 00000 n 0000055815 00000 n 0000056623 00000 n 0000064981 00000 n … �B�k ђ�f�]q۴ x���B�q�+\��� >��G��O� 0�� endstream endobj 19749 0 obj >stream application/postscript couv JPAD vol4-n3-2017 CTP01 2019-05-09T15:26:21+02:00 2019-05-09T15:26:21+02:00 2019-05-09T15:26:21+02:00 Adobe Illustrator CC 2017 (Macintosh) xmp.iid:eeded3b5-4cbe-46d3-a1d8-c24b4c56c472 xmp.did:eeded3b5-4cbe-46d3-a1d8-c24b4c56c472 uuid:5D20892493BFDB11914A8590D31508C8 proof:pdf xmp.iid:40fe59a7-b653-432f-b8e5-042fc342728c xmp.did:40fe59a7-b653-432f-b8e5-042fc342728c uuid … 018-01-18T09:27:10+01:00 Adobe Illustrator CC 2014 (Macintosh) / converted from application/postscript to application/vnd.adobe.illustrator saved xmp.iid:40fe59a7-b653-432f-b8e5-042fc342728c 2018-03-06T12:03:50+01:00 Adobe Illustrator CC 2017 (Macintosh) / converted from application/postscript to application/vnd.adobe.illustrator converted from application/postscript to application/vnd.adobe.illustrator converted from application/postscript to application/vnd.adobe.illustrato … from application/postscript to application/vnd.adobe.illustrator converted from application/postscript to application/vnd.adobe.illustrator saved xmp.iid:eeded3b5-4cbe-46d3-a1d8-c24b4c56c472 2019-05-09T15:26:21+02:00 Adobe Illustrator CC 2017 (Macintosh) / Print False False 1 219.000000 286.000000 Millimeters Times-Roman Times Regular TrueType 10.0d1e3 False Times.dfont Times-Bold Times Bold TrueType 10.0d1e3 False Times.dfont TimesNewRomanPSMT Times New Roman Regular Open Ty … 5+02:00 2018-04-24T16:08:25+02:00 itext-paulo-155 (itextpdf.sf.net-lowagie.com) application/pdf uuid:267f4a88-2b27-4a28-b766-37e0dbd74570 uuid:d63ba073-da32-44ec-b2e9-d597821cd4b1 endstream endobj 323 0 obj > endobj 324 0 obj >stream H��W[o�8~_i�C��J�8W �ԆҩV�UA��y3��h�8����9N��R:��ڍ��}��c�����ۤyJQ6i�qo�#�)��H)!⛏n�@�k������u�а{J�Ռ���8(�n�
Let's Talk! 5-STAR SECRET: Why top MA plans prioritize cognitive screening. Borrow their strategy! --> Products Science Customers Payers Providers More About us Blog News Patient education See Neurotrack in Action Find out why Neurotrack is the cognitive screening of choice for top health systems and 5-star Medicare Advantage plans. We'd love to give you a walkthrough. Use this form to tell us what you'd like to discuss. Our team will find a convenient time to connect. Need more info on Neurotrack? Check out our product Curious about our science? Review our clinical studies How does it be
%PDF-1.5 %���� 3152 0 obj > endobj xref 3152 68 0000000016 00000 n 0000003161 00000 n 0000003324 00000 n 0000007162 00000 n 0000007555 00000 n 0000007772 00000 n 0000008162 00000 n 0000008413 00000 n 0000008775 00000 n 0000008814 00000 n 0000009135 00000 n 0000009510 00000 n 0000009833 00000 n 0000009948 00000 n 0000010460 00000 n 0000010630 00000 n 0000011239 00000 n 0000011790 00000 n 0000012369 00000 n 0000012544 00000 n 0000013163 00000 n 0000013745 00000 n 0000013858 00000 n 0000014479 00000 n 0000015153 00000 n 0000015783 00000 n 0000015871 00000 n 0000016486 00000 n 0000017102 00000 n 0 … 02-c7c254c361e7 xmp.did:FE7F117407206811871FAC98DAC24824 default converted from application/x-indesign to application/pdf Adobe InDesign 15.1 (Macintosh) / 2020-10-20T12:49-05:00 application/pdf Adobe PDF Library 15.0 False 541935696 Lato OpenType - TT 541935696 -- 0 Lato-Regular 1.104 782929217 Lato OpenType - TT 782929217 -- 0 Lato-Bold 1.104 3744572246 Lato OpenType - TT 3744572246 -- 0 Lato-BoldItalic 1.104 2739485147 Helvetica TrueType 2739485147 Apple Computer 0 Helveti … 3c5b169c6b4 xmp.did:7ea69182-38e0-40c7-baae-9b7b02131d4e default converted from application/x-indesign to application/pdf Adobe InDesign 16.2 (Macintosh) / 2021-07-06T13:36:02-04:00 application/pdf Adobe PDF Library 15.0 False endstream endobj 296 0 obj > endobj xref 0 3152 0000000000 65535 f 0000117495 00000 n 0000121804 00000 n 0000129805 00000 n 0000221089 00000 n 0000312373 00000 n 0000321924 00000 n 0000391437 00000 n 0000391495 00000 n 0000392608 00000 n 0000415585 0000
Checking your browser - reCAPTCHA Checking your browser before accessing pmc.ncbi.nlm.nih.gov ... Click here if you are not automatically redirected after 5 seconds.
%PDF-1.7 %���� 1456 0 obj > endobj xref 1456 233 0000000016 00000 n 0000005916 00000 n 0000006153 00000 n 0000006198 00000 n 0000006236 00000 n 0000007013 00000 n 0000007121 00000 n 0000007236 00000 n 0000007352 00000 n 0000007462 00000 n 0000007577 00000 n 0000007685 00000 n 0000007801 00000 n 0000007911 00000 n 0000008026 00000 n 0000008142 00000 n 0000008252 00000 n 0000008367 00000 n 0000008475 00000 n 0000008591 00000 n 0000008707 00000 n 0000008817 00000 n 0000008933 00000 n 0000009043 00000 n 0000009159 00000 n 0000009269 00000 n 0000009385 00000 n 0000009495 00000 n 0000009611 00000 n … �\��� �����E�Z�c@��(�����m[Z }Q��͝�� Y��7�U�e_�� > endobj 1620 0 obj >stream application/postscript CrossMark_stacked Adobe Illustrator CS5 2014-03-10T17:56:01+05:30 2014-03-10T17:56:03+05:30 2014-03-10T17:56:03+05:30 228 256 JPEG /9j/4AAQSkZJRgABAgEASABIAAD/7QAsUGhvdG9zaG9wIDMuMAA4QklNA+0AAAAAABAASAAAAAEA
AQBIAAAAAQAB/+4ADkFkb2JlAGTAAAAAAf/bAIQABgQEBAUEBgUFBgkGBQYJCwgGBggLDAoKCwoK
DBAMDAwMDAwQDA4PEA8ODBMTFBQTExwbGxscHx8fHx8fHx8fHwEHBwcNDA0YEBAYGhURFRofHx8f
Hx8 … J4etwr6frV+zy+Hnw96Yq//9k= uuid:43F9A62F99BFE111B3B3AA974B5B975E converted from application/postscript to application/vnd.adobe.illustrator saved xmp.iid:829FFC960FC5E111B615DDB90E5BE10B 2012-07-03T18:34:14+05:30 Adobe Illustrator CS4 / converted from application/postscript to application/vnd.adobe.illustrator converted from application/postscript to application/vnd.adobe.illustrator converted from application/postscript to application/vnd.adobe.illustrator saved xmp.iid:85CB … :1a1bd3d9-b278-40e5-b891-51f7ba859a74 uuid:02518d8f-702e-4e48-903d-b1cb9c1fa7e7 application/postscript doi:10.1016/j.jalz.2007.04.375 endstream endobj 1625 0 obj > endobj 1626 0 obj >stream h���n�0������D�8�-�����BpX@�"�zmw�c�d��}5 ��q���=� 0���� endstream endobj 1627 0 obj > endobj 1628 0 obj >stream 2008-04-28T13:18:40Z 2008-04-28T13:18:40Z Illustrator JPEG 256 176 /9j/4AAQSkZJRgABAgEASABIAAD/7QAsUGhvdG9zaG9wIDMuMAA4QklNA+0AAAAAABAASAAAAAEA
AQBIAAAAAQAB/+4ADkFkb2Jl … f9XfzL/wBJF/8A81Yq7/FH53f9
XfzL/wBJF/8A81Yq7/FH53f9XfzL/wBJF/8A81Yq/wD/2Q== application/postscript endstream endobj 1629 0 obj > endobj 1630 0 obj > endobj 1631 0 obj > endobj 1632 0 obj > endobj 1633 0 obj > endobj 1634 0 obj > endobj 1635 0 obj > endobj 1636 0 obj > endobj 1637 0 obj > endobj 1638 0 obj > endobj 1639 0 obj > endobj 1640 0 o
Clinical Studies on Neurocognitive Testing and Intervention 5-STAR SECRET: Why top MA plans prioritize cognitive screening. Borrow their strategy! --> Products Science Customers Payers Providers More About us Blog News Patient education Everything we do is backed by science OUR BEGINNINGS Focused on Alzheimer's from day one Neurotrack was co-founded in 2012 by Elli Kaplan, Elizabeth Buffalo, Ph.D., Cecelia Manzanares, and cognitive impairment testing pioneer Stuart Zola, Ph.D. Collectively, our co-founders and clinical team members have authored 354 peer-reviewed papers Their research has been
Frontiers | Statistical Disease Progression Modeling in Alzheimer Disease Frontiers in Big Data About us About us Who we are Mission and values History Leadership Awards Impact and progress Frontiers' impact Our annual reports Thought leadership Publishing model How we publish Open access Quality and research integrity Peer review Research Topics Publish your data Fee policy Services Societies National consortia Institutional partnerships Collaborators More from Frontiers Frontiers Forum Frontiers Planet Prize Press office Sustainability Career opportunities Contact us All journals All art … office Sustainability Career opportunities Contact us All journals All articles Submit your research Search Frontiers in Big Data Sections Sections Big Data Networks Big Data and AI in High Energy Physics Cybersecurity and Privacy Data Analytics for Social Impact Data Mining and Management Data Science Data-driven Climate Sciences Machine Learning and Artificial Intelligence Medicine and Public Health Recommender Systems Articles Research Topics Editorial board About journal … rnal sections Open access statement Copyright statement Quality For authors Why submit? Article types Author guidelines Editor guidelines Publishing fees Submission checklist Contact editorial office About us About us Who we are Mission and values History Leadership Awards Impact and progress Frontiers' impact Our annual reports Thought leadership Publishing model How we publish Open access Quality and research integrity Peer review Research Topics Publish your data Fee p … partnerships Collaborators More from Frontiers Frontiers Forum Frontiers Planet Prize Press office Sustainability Career opportunities Contact us All journals All articles Submit your research Frontiers in Big Data Sections Sections Big Data Networks Big Data and AI in High Energy Physics Cybersecurity and Privacy Data Analytics for Social Impact Data Mining and Management Data Science Data-driven Climate Sciences Machine Learning and Artificial Intelligence Medicine and Publ … rnal sections Open access statement Copyright statement Quality For authors Why submit? Article types Author guidelines Editor guidelines Publishing fees Submission checklist Contact editorial office Frontiers in Big Data Sections Sections Big Data Networks Big Data and AI in High Energy Physics Cybersecurity and Privacy Data Analytics for Social
Custom AI Solutions for Business Growth | Neurotrack Home About us Cases Services AI Chatbot Development AI Voice Assistant AI Employee Onboarding AI Meeting Assistant Development Services Blog Partners Contacts English Polski Español Українська Portuguese English UK Leave a request Leave a request Custom AI Solutions for Business That Drive Growth and Automation Custom AI Solutions for Business That Drive Growth and Automation We deliver custom AI solutions for business that help companies automate processes, improve decision-making, and scale faster. From AI software development to enterpris … ance monitoring of employees AI employee onboarding AI-driven staff-free retail Submit a request Business Automation with AI Custom AI Solutions for Business Automation Automation is at the core of digital transformation. We develop custom AI solutions for business automation that replace manual workflows with intelligent systems powered by machine learning and data analysis. Our expertise includes: AI tools for business process automation Intelligent document processing Work
Online Cognitive Assessment Tests for Healthcare Providers, Health Systems 5-STAR SECRET: Why top MA plans prioritize cognitive screening. Borrow their strategy! --> Products Science Customers Payers Providers More About us Blog News Patient education Solutions for providers Quick, accurate cognitive assessments to identify cognitive impairment Rapid digital cognitive screening for annual wellness visits We know early diagnosis means better outcomes, and yet... Source: Today's Geriatric Medicine Source: Today's Geriatric Medicine Nearly 1/2 of patients are diagnosed late* *in moderate to
XBRL Viewer Please enable JavaScript to use the EDGAR Inline XBRL Viewer.
SEC FORM D/A The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. The reader should not assume that the information is accurate and complete. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Intentional misstatements or omissions of fact constitute federal criminal violations. See 18 U.S.C. 1001. FORM D Notice of Exempt Offering of Securities OMB APPROVAL OMB Number: 3235-0076 Estimated average burden hours per response: 4.00 1. Issuer's Identity CIK (Filer ID Number) Pre … ces Commercial Banking Insurance Investing Investment Banking Pooled Investment Fund Is the issuer registered as an investment company under the Investment Company Act of 1940? Yes No Other Banking & Financial Services Business Services Energy Coal Mining Electric Utilities Energy Conservation Environmental Services Oil & Gas Other Energy Health Care Biotechnology Health Insurance Hospitals & Physicians Pharmaceuticals X Other Health Care Manufacturing Real Estate … ot Applicable 6. Federal Exemption(s) and Exclusion(s) Claimed (select all that apply) Rule 504(b)(1) (not (i), (ii) or (iii)) Rule 504 (b)(1)(i) Rule 504 (b)(1)(ii) Rule 504 (b)(1)(iii) Rule 505 X Rule 506(b) Rule 506(c) Securities Act Section 4(a)(5) Investment Company Act Section 3(c) Section 3(c)(1) Section 3(c)(9) Section 3(c)(2) Section 3(c)(10) Section 3(c)(3) Section 3(c)(11) Section 3(c)(4) Section 3(c)(12) Section 3(c)(5) Section 3(c)(13) Section 3(c)(6) Section 3(c … more than one year? Yes X No 9. Type(s) of Securities Offered (select all that apply) X Equity Pooled Investment Fund Interests Debt Tenant-in-Common Securities Option, Warrant or Other Right to Acquire Another Security Mineral Property Securities X Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security X Other (describe) Offer and sale of shares of preferred stock and the underlying shares of common stock issuable upon conversion thereof … tate/Province/Country ZIP/Postal Code State(s) of Solicitation (select all that apply) Check “All States” or check individual States All States Foreign/non-US 13. Offering and Sales Amounts Total Offering Amount $ 10,859,199 USD or Indefinite Total Amount Sold $ 9,858,963 USD Total Remaining to be Sold $ 1,000,236 USD or Indefinite Clarification
Instagram See everyday moments from your close friends . Log into Instagram Mobile number, username or email Password Log in Forgot password? Log in with Facebook Create new account Meta About Blog Jobs Help API Privacy Terms Locations Popular Instagram Lite Meta AI Threads Contact Uploading & Non-Users Meta Verified English Down chevron icon Afrikaans العربية Čeština Dansk Deutsch Ελληνικά English English (UK) Español (España) Español فارسی Suomi Français עברית Bahasa Indonesia Italiano 日本語 한국어 Bahasa Melayu Norsk Nederlands Polski Português (Brasil) Português (Portugal) Русский Svenska ภ
Neurotrack Raises $21M in Series C Funding Accessibility Statement Skip Navigation Resources Investor Relations Journalists Agencies Client Login Send a Release News Products Contact Search Search When typing in this field, a list of search results will appear and be automatically updated as you type. Searching for your content... No results found. Please change your search terms and try again. News in Focus Browse News Releases All News Releases All Public Company English-only News Releases Overview Multimedia Gallery All Multimedia All Photos All Videos Multimedia Gallery Overview Trending T … es over $3.5M in grants from the National Institutes of Health and a fast-track grant worth up to $3.3 million from the National Institute on Aging.* The new investment will be used to advance the company's mission to change how people manage their cognitive health, drive adoption of its Memory Health Program, and continue development and partnerships in global markets. Neurotrack's Memory Health Program is a game-changer in the fight against Alzheimer's. With an estimated 50 … derlying technology, and in 2019, the company was the recipient of a fast-track grant worth up to $3.3 million from the National Institute on Aging. About Neurotrack Neurotrack is building the digital memory health platform of the future, giving people direct access to digital tools and technology to assess, preserve, and strengthen their memory health. The company was co-founded in 2012 by CEO Elli Kaplan , and leading neuroscientists and researchers Stuart Zola , PhD … tform Login ProfNet Data Privacy Do not sell or share my personal information : Submit via [email protected] Call Privacy toll-free: 877-297-8921 Contact PR Newswire Products About My Services All News Releases Platform Login ProfNet Call PR Newswire at 888-776-0942 Terms of Use Privacy Policy Information Security Policy Site Map RSS Cookies Copyright © 2026 Cision US Inc. --> -->
Georgia Research Alliance MENU Who We Are Trustees GRA Staff Senior Advisors Supporters Recruiting Talent Eminent Scholars Distinguished Investigators Senior Fellows Enhancing Labs Sharing Core Facilities Growing Companies Grants & Loans How to Apply Portfolio Greater Yield Initiative GRA Venture Fund Newsroom Features Blog GRA Notes Newsletter Publications Other GRA Initiatives Solve Sickle Cell Workforce Development DONATE NeuroTrack Technologies Industry: Software-based diagnostic for Alzheimer’s Disease Neurotrack creates tools for the early detection and prevention of Alzheimer&rsqu
Press Releases and Media Updates from Neurotrack 5-STAR SECRET: Why top MA plans prioritize cognitive screening. Borrow their strategy! --> Products Science Customers Payers Providers More About us Blog News Patient education Press Release Latest posts October 3, 2024 Elli Kaplan to Speak on Innovations in Dementia Detection Neurotrack Team Read more December 22, 2022 Coaching and Education Reduce Alzheimer's Risk Factors and Improve Cognition, According to Early Results from NIA-Funded Study Neurotrack Read more November 1, 2022 Neurotrack Develops 3-Minute Digital Test to Screen for Cognitiv … Impairment Neurotrack Read more April 17, 2019 Neurotrack Awarded $3.3 Million Grant from National Institute on Aging to Study the Impact of its Cognitive Health Digital Therapeutic Neurotrack Read more December 14, 2018 A Match Made in Cognitive Health Heaven: Neurotrack & Dai-ichi Life Join Forces Neurotrack Read more All posts Discover an efficient, effective way to screen cognition Solutions Products Providers Payers Contact us Company About us Careers News Science S
Comparison of genetic and health risk factors for mild cognitive impairment and Alzheimer's disease between Hispanic and non-Hispanic white participants Skip to main content Communities & Collections All of Scholar@UNT Health English العربية বাংলা Català Čeština Deutsch Ελληνικά Español Suomi Français Gàidhlig हिंदी Magyar Italiano Қазақ Latviešu Nederlands Polski Português Português do Brasil Srpski (lat) Српски Svenska Türkçe Yкраї́нська Tiếng Việt Log In (current) Home Texas College of Osteopathic Medicine Sid E. O'Bryant, Ph.D. Publications -- Sid E. O'Bryant Comparison of genetic and … Association Interactive Network (GAAIN), funded by the Alzheimer's Association (grant number SG-20-678486-GAAIN2) at the Mark and Mary Stevens Neuroimaging and Informatics Institute at Keck School of Medicine of USC. The primary goal of GAAIN is to advance research into the causes, prevention and treatment of Alzheimer's and other neurodegenerative diseases. The National Alzheimer's Coordinating Center (NACC) database is funded by NIA/NIH grant U24 AG072122. NACC data are con … ysis or writing of this report. ADNI is funded by National Institutes of Health grant U01 AG024904 and Department of Defense award number W81XWH-12-2-0012. ADNI is also funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: AbbVie, Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen; Bristol-Myers Squibb Company; Cer … f the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. dc.identifier.citation Xiao, C., Pappas, I., Aksman, L. M., O'Bryant, S. E., Toga, A. W., & Health and Aging Brain Study (HABS-HD) Study Team, Alzheimer's Disease Neuroimaging Initiative (2023). Comparison of genetic and health risk factors for mild cognitive impairment and Alzheimer's disease between Hispanic and non-Hispanic white participants. Alzheime
%PDF-1.5 %���� 1 0 obj > endobj 2 0 obj > endobj 3 0 obj >/ExtGState >/Font >/ProcSet[/PDF/Text/ImageB/ImageC/ImageI] >>/MediaBox[ 0 0 595.32 841.92] /Contents 6 0 R/Group >/Tabs/S>> endobj 4 0 obj > stream x��} sɕ�Oٍ�0���1�111�c�z��gz�m��v�}��j�(�Zj� ��'夫�B�X �^|� Yyիʯ�{��:���@ ���'�$�"���@ 1b8�$���@ 1b8�$���@ 1b8�$���@ 1b8�$���@ 1b8�$���@ 1b8�$���@ 1b8�$���@ 1b8�$���@ 1b8�$���@ 1b8�$���@ 1b8�$���@ 1b8�$���@ 1b8�$���@ 1b8�$���@ 1b8�$���@ 1b8�$���@ 1���w� �I"&���@ 1��d�H���D B�@�1�$���:�#PzL&��(�N�cR9��
MATTER Startup Spotlight: Neurotrack --> Learn more about Paratus — the BARDA Accelerator Network Hub for Digital Health. Click to explore opportunities... Learn more about Paratus — the BARDA Accelerator Network Hub for Digital Health. Click to explore opportunities... Log in to our member portal Startups Corporations Investors Insights Events Home Startups Overview Challenges Our startups Flex Select Corporations Overview Challenges Our partners Join Investors Overview Investor network Insights Blog Podcast Subscribe Events Overview Challenges Our startups Flex Select Overview Challenges Our
Terms of Use 5-STAR SECRET: Why top MA plans prioritize cognitive screening. Borrow their strategy! --> Products Science Customers Payers Providers More About us Blog News Patient education Terms of Use for Neurotrack Public Websites Last revised and effective: July 17, 2025 PLEASE READ THE FOLLOWING TERMS OF USE (“WEBSITE TERMS” OR “TERMS”) CAREFULLY AS THEY CONSTITUTE A LEGALLY BINDING CONTRACT BETWEEN YOU AND NEUROTRACK. BY ACCESSING OR USING THE PUBLIC WEBSITE AT www.neurotrack.com (INCLUDING ANY PUBLIC SUBDOMAINS THEREOF) (the “Site” or “Sites”) YOU ARE AGREEING TO ALL OF THESE WEBSITE TE … E SITE(S). IF YOU DISAGREE WITH ANY OF THESE WEBSITE TERMS, NEUROTRACK DOES NOT GRANT YOU ANY LICENSE OR RIGHT TO ACCESS OR USE THE SITE(S). NEUROTRACK MAY CHANGE THESE WEBSITE TERMS AT ANY TIME IN ITS DISCRETION BY POSTING UPDATED TERMS OF USE ON THE SITE(S). IF ANY MODIFICATION IS UNACCEPTABLE TO YOU, YOU MUST CEASE ACCESSING OR USING THE SITE(S). BY CONTINUING TO ACCESS OR USE ANY OF THE SITE(S) YOU WILL BE DEEMED TO HAVE ACCEPTED ALL SUCH CHANGES. The Site(s) are fo … y Neurotrack product or service offerings (“Services”), You will be required to submit a registration application to Neurotrack (as provided for on the Site) and agree to a separate Terms of Use for such Services. DISCLAIMER AND ACKNOWLEDGEMENT. NEUROTRACK DOES NOT AND CANNOT DIAGNOSE YOUR HEALTH CONDITION, PROVIDE A MEDICAL OPINION, AND/OR SUBSTITUTE FOR PROFESSIONAL MEDICAL ADVICE, through the Site(s), the Content, the Services, or otherwise. You acknowledge and agree that … w limitations on how long an implied warranty lasts, so this limitation may not apply to You. You may also have other rights which vary by jurisdiction, and which are not modified by this clause to the extent that doing so would breach such applicable law. 6. Limitation of Liability. 6.1. Exclusion of Consequential Damages and Limit of Liability. EXCEPT TO THE EXTENT REQUIRED BY APPLICABLE LAW, NEUROTRACK WILL NOT BE RESPONSIBLE FOR ANY LOST PROFITS, REVENUES, OR DATA, COST O … IS ALLOCATION OF RISKS AND THE LIMITATION OF LIABILITY AND SUCH LIMITATION WILL APPLY NOTWITHSTANDING A FAILURE OF ESSENTIAL PURPOSE OF ANY LIMITED REMEDY AND TO THE FULLEST EXTENT PERMITTED BY LAW. 7. Indemnification. You agree to indemnify, defend, and hold harmless Neurotrack and its affiliates, and its and their directors, officers, employees
Sutter Health's Cognitive Screening Breakthrough 5-STAR SECRET: Why top MA plans prioritize cognitive screening. Borrow their strategy! --> Products Science Customers Payers Providers More About us Blog News Patient education Innovation , Partner Story Sutter Health's Cognitive Screening Breakthrough An innovation challenge was the spark for a winning Sutter-Neurotrack partnership that's improving brain health care pathways in Northern California Neurotrack Team Published on January 13, 2026 3 min read Sutter Health, serving 3.5 million patients and consistently ranked among the top U.S. healt … ld. Each year we run an annual, system-wide innovation challenge and anyone can submit an idea on the platform. We then pass it through: Is it aligned, is it feasible, is it aligned with the strategy? And then the employee community votes up. We create semifinalists, and those finalists get a lot of support, and then we pick one. "An example of one that’s scaling right now: We picked a cognitive screener using digital tools that can be used at home. And the whole idea is that
Leading health care brands to exhibit at RISE National 2025 in March Skip to content Skip to menu Skip to footer About Events CEUs Insights & Articles Sponsor Webinar Library Who We Are Search Menu Close Search Leading health care brands to exhibit at RISE National 2025 in March Hundreds of leading health care brands and breakthrough innovators have signed on as sponsors of RISE’s annual Medicare Advantage mega-event in San Antonio, March 11-14. RISE is thrilled to announce that 141 sponsors will exhibit at RISE National 2025 —the annual event that is the #1 trusted source for all things M … lculated your 2027 Quality Bonus Payment (QBP) rating, and you know the June 22 deadline to tell CMS your intent. The announcement is settled. What isn't settled is the decision sitting on your desk: if your rating went up, is reopening your bid actually worth it, and if you decide it is, can you execute the changes in the days you have left? June 18, 2026 Insight AI in Medicare Advantage: everyone is moving, no one has the map Insight AI in Medicare Advantage: everyone i … rmanent. The program has operated through annual guidance since launch. The new proposal moves negotiation into codified regulation, starting with initial price applicability year 2029. For Part D and Part B leaders, pharmacy teams, and product strategists, the shift from yearly guidance to a durable framework changes how you plan for the next several cycles. June 16, 2026 See all articles ©2026 RISE, a part of Wilmington plc 3420 Toringdon Way, Suite 330, Charlotte, NC … am Customized Training Contact us Stay Informed General Inquiry Sponsor Inquiry Apply to Speak Press Passes Follow us Facebook Twitter LinkedIn Instagram Close
Blog | Joelle Klein 5-STAR SECRET: Why top MA plans prioritize cognitive screening. Borrow their strategy! --> Products Science Customers Payers Providers More About us Blog News Patient education Joelle Klein Joelle Klein is a health writer and frequent contributor to the Neurotrack blog. Latest posts February 10, 2024 The Evolution of Cognitive Testing Joelle Klein Read more August 23, 2023 Addressing the Elephant in the Room: How PCPs and Patients Can Talk About Memory Concerns Joelle Klein Read more July 4, 2023 3 Ways Your Cognitive Screening Workflow Is Working Against You Joelle Klein R
Jan 27-29, 90+ Exhibitors at PMWC 2027 Silicon Valley Chat with us , powered by LiveChat Skip to content Chats Contact Speakers Agenda Tickets Menu FULL MENU FULL MENU Register here Rates by JUL. 2 Register here PMWC, Jan 25-27, 2023 PMWC - Silicon valley, ca January 27-29, 2027 Past Event PMWC, Feb 5-7, 2025 PMWC - Silicon valley, ca January 27-29, 2027 Attend Program Schedule Sessions Honorees Speakers Company Competition Showcases Travel Venue Sightseeing Reduced Rates Hotel Flights Exhibits + Map Login / My Account Participate REGISTER TO EXHIBIT Prospectus Attendee Breakdown Apply to spea … ogin / My Account Participate Register to Exhibit Prospectus Attendee Breakdown Apply to speak Sponsorship Inquiry GET UPDATES ABOUT Mission Testimonial Past Conferences Past Honorees Past Speakers FAQ CONTACT US Menu agenda speakers exhibits Contact us agenda speakers exhibits Contact us BUY TICKETS SAVE $1351 BY JUL. 2 Menu Item #1 Item #1 PMWC - Silicon valley, ca Jan. 27-29, 2027 Pittsburgh, pa sep. 23-24 PMWC - Silicon valley, ca Jan. 27-29, 2027 Register Here Rates by J … tend Program Speakers Travel Exhibits + Map Main Program View your save program Award Reception Speaker gallery Select part speakers Exhibit gallery Part conferences Participate Register to Exhibit Apply to speak Sponsorship Inquiry ABOUT Login / My Account CONTACT US Get Updates Pittsburgh, pa sep. 23-24 Register Here Rates by Attend Program Travel Reduced Rates Exhibits + Map Main Program View your save program Award Reception Paticipate Register to Exibit Apply to speak Sp … nomix Labs Alphaexpeditions Alpine Alquest Therapeutics ALS Emergency Treatment Fund Alta Bates Summit Comprehensive Cancer Center Alta Devices AltaQ Altered Egos Comics AltheaDx Althia Altiora Altis Biosystems, LLC Altoida Inc Altos Labs AltruBio Altum Medical Alum Alumot – sprint Aluna Health Alva10 Alveo Technologies Alverno Laboratories AlwaysRx Alykomed Global Solutions LLC Alykomedglobal Alzheimer’s X Alzheon AMA Ama-Assn Amaro Therapeutics Amazon Amber Health Amb … Y Ancestry Anderson Cancer Center Andreessen Horowitz Andrew Andy Strouse Angel Fund Angel Investor ANGLE Biosciences ANGLE Europe Ltd. ANGLE, plc Angleplc Angstrom Bio Angular Medicine Anima AnjaGen Consulting Anl Annai Systems, Inc Annexon Biosciences Annexon Inc Annexonbio Anocca Ansun Biopharma Antenna Anthem Anthony Pastena, M.D. ,P.C Anthos
Blog | Amanda Ivanovics 5-STAR SECRET: Why top MA plans prioritize cognitive screening. Borrow their strategy! --> Products Science Customers Payers Providers More About us Blog News Patient education Amanda Ivanovics Chief Growth Officer Latest posts June 12, 2026 From Detection to Direction: What the Data on In-Home Cognitive Screening Means for Health Plans Amanda Ivanovics Read more April 29, 2026 The Underdetection Crisis. Why 80% of Seniors Aren't Getting Routine Cognitive Screening and What CMS Just Did About It Amanda Ivanovics Read more All posts Discover an efficient, effective way t
Neurotrack - 2024 FMX Skip to Main Content Neurotrack Event starts in: 00 DAYS 00 HRS 00 MINS 00 SECS September 24 to September 28, 2024 Phoenix Convention Center Phoenix, AZ Exhibitor Directory Exhibitor Listings Floorplan Login Register Neurotrack Booth #1508 About About Contact About Contact Name Neurotrack What We Do Neurotrack makes best-in-class, FDA-registered cognitive screening tools that outperform traditional pen-and-paper tests in sensitivity, specificity, and ease of use. We can help you identify and monitor cognitive impairment in any population, anywhere, in as little as 3 minut … nization Member List Emily Lapkin Video Listing Filter By My Videos Clear Close Apply Filter Date Date Name Relevance Elli Kaplan on Product in HealthTech Podcast © 2026 Powered by A2Z Events
Neurotrack Technologies, Inc | Alzheimer's Drug Discovery Foundation Donate Email Sign Up Search Search Submit Twitter Facebook YouTube Linkedin About Us Our Founders Staff Leadership Young Professionals Committee Our Impact Our Partners Annual Reports & Financials Careers Alzheimer's Disease What is Alzheimer's? Alzheimer's Causes Diagnosis & Treatment Alzheimer's Prevention Patient & Family Resources Research Our Research Strategy Funding Opportunities COVID-19 FAQ Diagnostics Accelerator SpeechDx Goodes Prize Our Portfolio Portfolio Highlights Reporting For Funded Projects ADDF Reports Even … Conditions Privacy Policy Close DONATE SIGN UP Twitter Facebook YouTube Search* Submit About Us Our Founders Staff Leadership Young Professionals Committee Our Impact Our Partners Annual Reports & Financials Careers Alzheimer's Disease What is Alzheimer's? Alzheimer's Causes Diagnosis & Treatment Alzheimer's Prevention Patient & Family Resources Research Our Research Strategy Funding Opportunities Diagnostics Accelerator Melvin R. Goodes Prize
Stewart Zola - Scientific Co-Founder at Neurotrack | The Org Platform Enrich Pricing Log in Sign up Neurotrack Stewart Zola Unverified Stewart Zola Scientific Co-Founder Contact No bio yet Org chart View org chart This person is not in the org chart Teams View all teams Scientific Team 3 people, 0 jobs Offices View all offices This person is not in any offices Related people Cory Berkland Bond Biosciences Nachshon Meiran Glimpse.io Kunal Masania sallea Connor Tsuchida Azalea Therapeutics Marissa Scavuzzo Rise Up: Northeast Ohio Maria D. Chatzidaki BeConscious.GR View more Company About Conta
Elli Kaplan - Executive Bio, Work History, and Contacts - Equilar ExecAtlas Request a Demo Win Deals Through Your Network Transform relationships with clients, colleagues, and partners into actionable insights. Search for an Executive Trusted by Trusted by Featured Profile Elli Kaplan Co-Founder and Chief Executive Officer at NeuroTrack Technologies, Inc. Elli Kaplan 's Executive Work History Current Co-Founder and Chief Executive Officer , Co-Founder and Chief Executive Officer Equilar on 07/30/2025 NeuroTrack Technologies, Inc. Past To view Elli Kaplan's complete executive work history, sign
Neurotrack Technologies Inc | www.inknowvation.com --> --> --> --> --> --> --> > https://gasparesganga.com/labs/jquery-loading-overlay/#examples --> > https://gasparesganga.com/labs/jquery-loading-overlay/#examples --> Skip to main content idi Toggle navigation 0 You have 0 notifications Site Visitor Site Visitor New To Inknowvation.com? Register now to get an access to proprietary SBIR-STTR databases! Registration is fast and free - start your access to business-actionable information today! Login Site Register Home My Work Area About My Work Area SBIR Community About SBIR Community SBIR Awar … ness Identifier: Pre-symptomatic Alzheimers diagnostic Year Founded 2012 First Award 2014 Latest Award 2022 Program Status Active : At least one SBIR-STTR award (Phase I or Phase II) in last five years Inactive : Last award dollars more than FIVE years ago"> Program Status Active Popularity Index The Popularity Index is a rank (scale 1-100) assigned to each SBIR company, based on the number of hits to the company record. Currently Most Popular - click the name to see - … password. Please enter email address that is associated with your account. Back Submit ' type='hidden'> Still Need Help? If you need further assistance, send us an e-mail and we will assist you in resetting your account. Forgot password? Mail sent successfully. Enter username and password. Please enter email address that is associated with your account. Back Submit ' type='hidden'> Still Need Help? If you need further assistance, send us an e-mail and we will assist you in re
Jeff Magnusson - Executive Bio, Work History, and Contacts - Equilar ExecAtlas Request a Demo Win Deals Through Your Network Transform relationships with clients, colleagues, and partners into actionable insights. Search for an Executive Trusted by Trusted by Featured Profile Jeff Magnusson Chief Technology Officer at NeuroTrack Technologies, Inc. Jeff Magnusson 's Executive Work History Current Chief Technology Officer , Chief Technology Officer Equilar on 07/30/2025 NeuroTrack Technologies, Inc. Past To view Jeff Magnusson's complete executive work history, sign up now Jeff Magnusson 's Conn
It’s Personal: How My Family’s Alzheimer’s Journey Led to Scientific Breakthroughs 5-STAR SECRET: Why top MA plans prioritize cognitive screening. Borrow their strategy! --> Products Science Customers Payers Providers More About us Blog News Patient education From the CEO , Innovation It’s Personal: How My Family’s Alzheimer’s Journey Led to Scientific Breakthroughs CEO Elli Kaplan saw huge advances being made in treating other diseases through screening and behavior change, and knew brain health could benefit from the same approach. Elli Kaplan Published on June 1, 2023 3 min read “Shun
Elli Kaplan to Speak on Innovations in Dementia Detection 5-STAR SECRET: Why top MA plans prioritize cognitive screening. Borrow their strategy! --> Products Science Customers Payers Providers More About us Blog News Patient education Press Release Elli Kaplan to Speak on Innovations in Dementia Detection Neurotrack's CEO will address the latest breakthroughs in dementia detection in two upcoming events. Learn more about the NEHI webinar and HLTH conference panel discussion happening in October 2024. Neurotrack Team Published on October 3, 2024 3 min read (PRESS RELEASE) Neurotrack , maker of
From the CEO of Neurotrack Cognitive Screening 5-STAR SECRET: Why top MA plans prioritize cognitive screening. Borrow their strategy! --> Products Science Customers Payers Providers More About us Blog News Patient education From the CEO Latest posts July 21, 2023 The Brain Health Secrets I Want Everyone to Know Elli Kaplan Read more June 29, 2023 Is It Brain Fog or Is It Alzheimer’s? Neurotrack Read more June 1, 2023 It’s Personal: How My Family’s Alzheimer’s Journey Led to Scientific Breakthroughs Elli Kaplan Read more April 4, 2023 It's Time for a Brain Checkup in Primary Care Elli Kap
Blog | Elli Kaplan 5-STAR SECRET: Why top MA plans prioritize cognitive screening. Borrow their strategy! --> Products Science Customers Payers Providers More About us Blog News Patient education Elli Kaplan Elli Kaplan is the co-founder and CEO of Neurotrack. Her career spans two decades in the public and private sectors, including leadership positions at the White House, State and Treasury Departments, and the United Nations, where she was the Deputy Chief of Staff for UNDP, the largest UN agency. She has won numerous awards including San Francisco Business Chronicle’s “Most Influential Wome
Skip to content How It Works Pricing Blog Events Partners Search orgs, people, news, resources... ⌘K Sign In Get Started → Search organizations, people, news, resources, and content... / How It Works Pricing Blog Events Partners Sign In Get Started → Loading organizations... The OS for early-stage founders from day zero to raise. Subscribe Product How It Works Pricing Partners Resources Blog Events Contact Company About Privacy Terms © 2026 Startup Intros, Inc. San Francisco, CA · Made for Founders Neurotrack: Funding, Team & Investors | Startup Intros Home / Organizations / Neurotrack § P … res , Mark Wahlberg , Steve Aoki , Marc Benioff , AME Cloud Ventures , Founders Fund , Samir Kaul , Jenny Abramson , Social Capital Announced Jan 27, 2016 $6.5M Venture Round Khosla Ventures AME Cloud Ventures , Founders Fund , ISeed Ventures , Social Capital Announced Dec 29, 2014 $1M Debt Financing — — Announced Sep 27, 2013 $2M Series A Peter Thiel Chamath Palihapitiya Announced May 22, 2013 $90K Seed — — Announced
Web Camera Based Eye Tracking to Assess Visual Memory on a Visual Paired Comparison Task Web Camera Based Eye Tracking to Assess Visual Memory on a Visual Paired Comparison Task Front Neurosci . 2017 Jun 28:11:370. doi: 10.3389/fnins.2017.00370. eCollection 2017. Authors Nicholas T Bott 1 , Alex Lange 2 , Dorene Rentz 3 4 , Elizabeth Buffalo 2 5 , Paul Clopton 6 , Stuart Zola 2 7 Affiliations 1 Department of Medicine, School of Medicine, Stanford UniversityStanford, CA, United States. 2 Neurotrack Tech
A new brain health app from Neurotrack warns users of memory decline | TechCrunch –:–:–:– The first StrictlyVC of 2026 hits SF on April 30. Tickets are going fast. Register now. Founder Summit ticket savings of up to $190 end June 26. Join 1,000+ founders and VCs for all-day bootcamp. REGISTER NOW. Close TechCrunch Desktop Logo TechCrunch Mobile Logo Latest Startups Venture Apple Security AI Apps Disrupt 2026 Events Podcasts Newsletters Search Submit Site Search Toggle Mega Menu Toggle Topics Latest AI Amazon Apps Biotech & Health Climate Cloud Computing Commerce Cr … Neurotrack has raised $9.5 million in equity funding to-date and $1 million in grant funding from NIH, Johnson & Johnson and the Georgia Research Alliance (GRA) to develop its technology and begin publishing some of its neuroscientific findings. Topics Alzheimer’s , Biotech & Health , Cecelia Manzanares , Computer Vision , dementia , digital health , Elizabeth Buffalo , eye tracking , Media & Entertainment , neuroscience , Neurotrack , Startups , Stuart Zol